Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:11814619rdf:typepubmed:Citationlld:pubmed
pubmed-article:11814619lifeskim:mentionsumls-concept:C0003018lld:lifeskim
pubmed-article:11814619lifeskim:mentionsumls-concept:C0006100lld:lifeskim
pubmed-article:11814619lifeskim:mentionsumls-concept:C0220781lld:lifeskim
pubmed-article:11814619lifeskim:mentionsumls-concept:C1883254lld:lifeskim
pubmed-article:11814619lifeskim:mentionsumls-concept:C0205464lld:lifeskim
pubmed-article:11814619lifeskim:mentionsumls-concept:C0243071lld:lifeskim
pubmed-article:11814619lifeskim:mentionsumls-concept:C0871161lld:lifeskim
pubmed-article:11814619pubmed:issue1lld:pubmed
pubmed-article:11814619pubmed:dateCreated2002-1-29lld:pubmed
pubmed-article:11814619pubmed:abstractTextAngiotensin II (AngII) and bradykinin (BK) derivatives containing the TOAC (2,2,6,6-tetramethylpiperidine-N-oxyl-4-amino-4-carboxylic acid) spin label were synthesized by solid phase methodology. Ammonium hydroxide (pH 10, 50 degrees C, l h) was the best means for reverting nitroxide protonation occurring during peptide cleavage. EPR spectra yielded rotational correlation times for internally labeled analogs that were nearly twice as large as those of N-terminally labeled analogs. Except for TOAC(1)-AngII and TOAC(0)-BK, which showed high intrinsic activities, other derivatives were inactive in smooth muscle preparations. These active paramagnetic analogs may be useful for conformational studies in solution and in the presence of model and biological membranes.lld:pubmed
pubmed-article:11814619pubmed:languageenglld:pubmed
pubmed-article:11814619pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11814619pubmed:citationSubsetIMlld:pubmed
pubmed-article:11814619pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11814619pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11814619pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11814619pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11814619pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11814619pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11814619pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11814619pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11814619pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11814619pubmed:statusMEDLINElld:pubmed
pubmed-article:11814619pubmed:monthJanlld:pubmed
pubmed-article:11814619pubmed:issn0196-9781lld:pubmed
pubmed-article:11814619pubmed:authorpubmed-author:PaivaT BTBlld:pubmed
pubmed-article:11814619pubmed:authorpubmed-author:NakaieC RCRlld:pubmed
pubmed-article:11814619pubmed:authorpubmed-author:SchreierSSlld:pubmed
pubmed-article:11814619pubmed:authorpubmed-author:SilvaE GEGlld:pubmed
pubmed-article:11814619pubmed:authorpubmed-author:MarchettoRRlld:pubmed
pubmed-article:11814619pubmed:authorpubmed-author:CilliE MEMlld:pubmed
pubmed-article:11814619pubmed:authorpubmed-author:PaivaA C MAClld:pubmed
pubmed-article:11814619pubmed:issnTypePrintlld:pubmed
pubmed-article:11814619pubmed:volume23lld:pubmed
pubmed-article:11814619pubmed:ownerNLMlld:pubmed
pubmed-article:11814619pubmed:authorsCompleteYlld:pubmed
pubmed-article:11814619pubmed:pagination65-70lld:pubmed
pubmed-article:11814619pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:11814619pubmed:meshHeadingpubmed-meshheading:11814619...lld:pubmed
pubmed-article:11814619pubmed:meshHeadingpubmed-meshheading:11814619...lld:pubmed
pubmed-article:11814619pubmed:meshHeadingpubmed-meshheading:11814619...lld:pubmed
pubmed-article:11814619pubmed:meshHeadingpubmed-meshheading:11814619...lld:pubmed
pubmed-article:11814619pubmed:meshHeadingpubmed-meshheading:11814619...lld:pubmed
pubmed-article:11814619pubmed:meshHeadingpubmed-meshheading:11814619...lld:pubmed
pubmed-article:11814619pubmed:meshHeadingpubmed-meshheading:11814619...lld:pubmed
pubmed-article:11814619pubmed:meshHeadingpubmed-meshheading:11814619...lld:pubmed
pubmed-article:11814619pubmed:meshHeadingpubmed-meshheading:11814619...lld:pubmed
pubmed-article:11814619pubmed:meshHeadingpubmed-meshheading:11814619...lld:pubmed
pubmed-article:11814619pubmed:meshHeadingpubmed-meshheading:11814619...lld:pubmed
pubmed-article:11814619pubmed:meshHeadingpubmed-meshheading:11814619...lld:pubmed
pubmed-article:11814619pubmed:meshHeadingpubmed-meshheading:11814619...lld:pubmed
pubmed-article:11814619pubmed:meshHeadingpubmed-meshheading:11814619...lld:pubmed
pubmed-article:11814619pubmed:meshHeadingpubmed-meshheading:11814619...lld:pubmed
pubmed-article:11814619pubmed:meshHeadingpubmed-meshheading:11814619...lld:pubmed
pubmed-article:11814619pubmed:meshHeadingpubmed-meshheading:11814619...lld:pubmed
pubmed-article:11814619pubmed:meshHeadingpubmed-meshheading:11814619...lld:pubmed
pubmed-article:11814619pubmed:meshHeadingpubmed-meshheading:11814619...lld:pubmed
pubmed-article:11814619pubmed:meshHeadingpubmed-meshheading:11814619...lld:pubmed
pubmed-article:11814619pubmed:meshHeadingpubmed-meshheading:11814619...lld:pubmed
pubmed-article:11814619pubmed:meshHeadingpubmed-meshheading:11814619...lld:pubmed
pubmed-article:11814619pubmed:meshHeadingpubmed-meshheading:11814619...lld:pubmed
pubmed-article:11814619pubmed:year2002lld:pubmed
pubmed-article:11814619pubmed:articleTitleSynthesis and pharmacological properties of TOAC-labeled angiotensin and bradykinin analogs.lld:pubmed
pubmed-article:11814619pubmed:affiliationDepartment of Biophysics, Universidade Federal de São Paulo, Rua Botucatu 862, 04023-062, SP, São Paulo, Brazil.lld:pubmed
pubmed-article:11814619pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:11814619pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11814619lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11814619lld:pubmed